Zacks Investment Research on MSN
Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings?
Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report third-quarter 2025 results on Oct. 30, after market close.
Gilead Sciences, Inc. (GILD), headquartered in Foster City, California, is a biopharmaceutical company that discovers, ...
Biotech giant Gilead Sciences, Inc. GILD has gained 16.8% in the past three months compared with the industry’s growth of 7.6%. The stock has also outperformed the sector and the S&P 500. The stock’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback